Related Experiment Video
Updated: May 2, 2026
07:49
Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos
Published on: August 25, 2019
10.2K
C1 esterase inhibitor activity in amniotic fluid embolism
Naoaki Tamura1, Satoshi Kimura, Mustari Farhana
11Department of Obstetrics and Gynaecology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. 2Department of Obstetrics and Gynaecology, Mie University School, Mie, Japan.
Critical Care Medicine
|February 25, 2014
Summary
Low C1 esterase inhibitor activity is linked to amniotic fluid embolism. This finding suggests C1 esterase inhibitor levels may predict amniotic fluid embolism prognosis.
Area of Science:
- Obstetrics and Gynecology
- Immunology
- Coagulation Science
Background:
- Amniotic fluid embolism (AFE) involves complex systemic activation, including complement and coagulation pathways.
- C1 esterase inhibitor (C1-INH) is a critical regulator of these systems and its activity is reduced during pregnancy.
- Understanding C1-INH levels in AFE is crucial for elucidating disease mechanisms.
Purpose of the Study:
- To investigate C1 esterase inhibitor activity levels in patients diagnosed with amniotic fluid embolism.
- To assess the correlation between C1-INH levels and AFE severity, including fatal outcomes.
Main Methods:
- Retrospective study conducted at a single university medical center.
- Analysis of 106 amniotic fluid embolism cases and 88 control deliveries between 2010-2011.
- Measurement of C1 esterase inhibitor activity levels in patient and control groups.
Main Results:
- C1 esterase inhibitor activity was significantly lower in AFE patients (30.0%) compared to controls (62.0%).
- Fatal AFE cases exhibited markedly lower C1-INH activity (22.5%) than nonfatal cases (32.0%).
- Statistical significance was observed for both comparisons (p < 0.0001 and p < 0.05, respectively).
Conclusions:
- Reduced C1 esterase inhibitor activity is strongly associated with the pathogenesis of amniotic fluid embolism.
- C1 esterase inhibitor activity levels show potential as a prognostic biomarker for amniotic fluid embolism.
- Further research may explore therapeutic interventions targeting C1-INH in AFE.
